Latest news from across the biotech industry
Internal FDA documents discovered via the Freedom of Information Act indicate a potential FDA bias against health-focused innovation and in favor of industrial corn sweetener producers.
What does Storyware do? Storyware is in the business of crafting creative digital solutions for our clients. This includes designing websites, building web applications, providing digital platform consulting and strategy,...
$8 Million Investment to Fund Cutting-Edge Research, Launch Clinical Trials, Create Jobs
Bonumose was selected for its contributions in the fields of nutrition & health.
Late next year, dermatologists will be able to submit a biopsy for genetic analysis and Ampel will then identify the best drugs for treatment.
The research collaboration agreement will further evaluate the Company’s proprietary adenosine analogs as a potential treatment for inflammatory diseases.
AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat inflammatory skin diseases.
A Multi-Enzyme Blend Was Tested and Validated in a Newly Adapted In Vitro Digestion Simulation Protocol
This is the company’s 5th FDA Clearance expanding the capabilities of its industry leading VitalStream™ wireless wearable.
The MicroGEM Sal6830 SARS-CoV-2 Saliva Test is the nation’s first point of care PCR saliva test for COVID-19, delivering results in minutes.
Dr. Tropsha will spearhead efforts to bring Contraline’s male contraceptive device, ADAM™, towards FDA approval
EIR expansion deepens BioHub’s bench of expertise to advance entrepreneurship in the regional ecosystem